-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100

Benzinga·07/16/2026 16:04:40
语音播报
Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $115 to $100.